PADCEV Patient Assistance Program
The PADCEV Patient Assistance Programa (PAP) provides PADCEVTM (enfortumab vedotin-ejfv) at no cost to uninsured patients who meet the program eligibility requirements.
PADCEV Support SolutionsSM will evaluate a patient's eligibility for the PAP program.
For more information, contact us at 1‑888‑402‑0627. We are available Monday–Friday, 8:30 am–8:00 pm ET.
Your patient may be eligible for the PAP program if he or she:
- Does not have insurance or has insurance that excludes coverage for PADCEV,a
- Has a verifiable shipping address in the United States,
- Has been prescribed PADCEV for an FDA-approved indication, AND
- Meets the program financial eligibility requirements
PADCEV Support Solutions is a component of Astellas Pharma Support SolutionsSM.
aProgram subject to eligibility restrictions and program terms and conditions.
PADCEVTM is a trademark jointly owned by Agensys, Inc. and Seattle Genetics, Inc.